0001104659-21-070018 Sample Contracts

DATED JANUARY 22, 2021 THE SERIES C INVESTORS and THE SERIES B INVESTORS and THE SERIES A INVESTORS and THE QUALIFYING ORDINARY SHAREHOLDERS and IMMUNOCORE HOLDINGS LIMITED SHAREHOLDERS’ AGREEMENT relating to Immunocore Holdings Limited Contents
Shareholders’ Agreement • May 20th, 2021 • Baker Bros. Advisors Lp • Biological products, (no disgnostic substances) • New York
Sample 1Sample 2
AutoNDA by SimpleDocs
JOINT FILING AGREEMENT
Joint Filing Agreement • May 20th, 2021 • Baker Bros. Advisors Lp • Biological products, (no disgnostic substances)

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13D (and any amendments thereto) need be filed with respect to the beneficial ownership by each of the undersigned of securities of Immunocore Holdings plc.

Sample 1
January 22, 2021 Baker Brothers Investments New York, NY 10014
Baker Bros. Advisors Lp • May 20th, 2021 • Biological products, (no disgnostic substances)

In connection with the 27,457,400 series C preferred shares with a nominal value of £0.0001 each in the share capital of Immunocore Holdings Limited (the “Company”) held by funds advised by Baker Bros. Advisors LP (“BBA”) (together, the “Shares”), the parties to this letter agreement (the “Letter Agreement”) hereby set forth herein and further agree as follows:

Sample 1
Immunocore Limited Lock-Up Agreement
Agreement • May 20th, 2021 • Baker Bros. Advisors Lp • Biological products, (no disgnostic substances)
Sample 1
Time is Money Join Law Insider Premium to draft better contracts faster.